中慧生物-B香港IPO获得超4000倍超额认购

格隆汇APP
Aug 08, 2025

格隆汇8月8日|香港IPO新股中慧生物-B公开发售据悉录得超4000倍超额认购,金额超2000亿港币,成为今年港股新股18A生物科技超购王。VanCapital、InfiniCapital等全球知名长线基金积极参与。

海量资讯、精准解读,尽在新浪财经APP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10